Home/Filings/4/0001567619-23-005287
4//SEC Filing

Burkhart Erin 4

Accession 0001567619-23-005287

CIK 0001048477other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 9:26 PM ET

Size

6.8 KB

Accession

0001567619-23-005287

Insider Transaction Report

Form 4
Period: 2023-03-15
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2023-03-15+3,76014,890 total
  • Award

    Stock Option (Right to buy Common Stock)

    2023-03-15+5,7205,720 total
    Exercise: $87.74From: 2024-03-15Exp: 2033-03-14Common Stock (5,720 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on March 15, 2023. Price not applicable.
  • [F2]Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.

Documents

1 file

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001927648

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:26 PM ET
Size
6.8 KB